Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons
- 1 May 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (2) , 259-269
Abstract
Whole‐cell patch clamp experiments were used to investigate the transduction mechanism of adenosine A2A receptors in modulating N‐methyl‐D‐aspartate (NMDA)‐induced currents in rat striatal brain slices. The A2A receptor agonist 2‐p‐(2‐carboxyethyl)phenethylamino‐5′‐N‐ethylcarboxamidoadenosine (CGS 21680) inhibited the NMDA, but not the (S)‐α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) current in a subset of striatal neurons. Lucifer yellow‐filled pipettes in combination with immunostaining of A2A receptors were used to identify CGS 21680‐sensitive cells as typical medium spiny striatal neurons. Dibutyryl cyclic AMP and the protein kinase A activator Sp‐cyclic AMPs, but not the protein kinase A inhibitors Rp‐cyclic AMPS or PKI(14–24)amide abolished the inhibitory effect of CGS 21680. The phospholipase C inhibitor U‐73122, but not the inactive structural analogue U‐73343 also interfered with CGS 21680. The activation of protein kinase C by phorbol 12‐myristate 13‐acetate or the blockade of this enzyme by staurosporine did not alter the effect of CGS 21680. Heparin, an antagonist of inositol 1,4,5‐trisphosphate (InsP3) and a more efficient buffering of intracellular Ca2+ by BAPTA instead of EGTA in the pipette solution, abolished the CGS 21680‐induced inhibition. The calmodulin antagonist W‐7 and cytochalasin B which enhances actin depolymerization also prevented the effect of CGS 21680; the calmodulin kinase II inhibitors CaM kinase II(281–309) and KN‐93 but not the inactive structural analogue KN‐92 were also effective. The calcineurin inhibitor deltamethrin did not interfere with CGS 21680. It is suggested that the transduction mechanism of A2A receptors to inhibit NMDA receptor channels is the phospholipase C/InsP3/calmodulin and calmodulin kinase II pathway. The adenylate cyclase/protein kinase A and phospholipase C/protein kinase C pathways do not appear to be involved. British Journal of Pharmacology (2000) 130, 259–269; doi:10.1038/sj.bjp.0703234Keywords
This publication has 59 references indexed in Scilit:
- Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neuronsAmino Acids, 1998
- Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neuronesBritish Journal of Pharmacology, 1997
- A2 adenosine receptors: their presence and neuromodulatory role in the central nervous systemGeneral Pharmacology: The Vascular System, 1996
- A Novel Highly Specific and Potent Inhibitor of Calmodulin-Dependent Protein Kinase IIBiochemical and Biophysical Research Communications, 1995
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Protein kinase C: is its pivotal role in cellular activation over-stated?Trends in Pharmacological Sciences, 1994
- Calcium-induced actin depolymerization reduces NMDA channel activityNeuron, 1993
- The newly synthesized selective Ca2+calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cellsBiochemical and Biophysical Research Communications, 1991
- The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neuronesTrends in Neurosciences, 1990
- N6-Bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptorJournal of Medicinal Chemistry, 1989